Skip to Content
Merck
CN
  • Simultaneous estimation of etoricoxib and thiocolchicoside by RP-HPLC method in combined dosage forms.

Simultaneous estimation of etoricoxib and thiocolchicoside by RP-HPLC method in combined dosage forms.

Acta poloniae pharmaceutica (2011-12-01)
Sanjiv Kumar, Amit Joshi, Rahul Singh Thakur, Anupam K Pathak, Kamal Shah
ABSTRACT

A simple, reproducible and efficient reverse phase high performance liquid chromatographic method was developed for simultaneous estimation of etoricoxib and thiocolchicoside in combined tablet dosage form. Formulation containing etoricoxib and thiocolchicoside is used as analgesic. Chromatography was performed on a 250 mm x 4.6 mm, 5-microm particle size, BDS Hypersil C-18 column with trifluoroacetic acid buffer (pH 2.6) and acetonitrile (75:25, v/v) as a mobile phase. The detection of the combined dosage form was carried out at 220 nm and a flow rate employed was 1.5 mL/min. The retention times were 6.6 and 3.1 min for etoricoxib and thiocolchicoside, respectively. Linearity was obtained in the concentration range 20 to 160 ppm for etoricoxib and in the range 2 to 16 ppm for thiocolchicoside with a correlation coefficient of 0.9918 and 0.9994, respectively. The results of the analysis were validated statistically and recovery studies confirmed the accuracy and precision of the proposed method.

MATERIALS
Product Number
Brand
Product Description

Supelco
Etoricoxib, VETRANAL®, analytical standard